Carsten Höltke Selected Research

gadofluorine P

1/2020	Mass Spectrometry Imaging of atherosclerosis-affine Gadofluorine following Magnetic Resonance Imaging.
4/2018	Molecular imaging of myocardial infarction with Gadofluorine P - A combined magnetic resonance and mass spectrometry imaging approach.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carsten Höltke Research Topics

Disease

18	Neoplasms (Cancer) 01/2022 - 01/2008
5	Atherosclerosis 11/2020 - 05/2005
5	Neoplasm Metastasis (Metastasis) 01/2020 - 05/2005
3	Atherosclerotic Plaque (Atheroma) 11/2020 - 11/2008
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 10/2009
3	Infarction (Infarctions) 04/2018 - 03/2013
2	Myocardial Infarction 01/2020 - 04/2018
2	Fibrosarcoma 12/2016 - 09/2014
2	Inflammation (Inflammations) 05/2008 - 05/2005
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Cicatrix (Scar) 04/2018
1	Colitis 12/2017
1	Colitis-Associated Neoplasms 12/2017
1	Melanoma (Melanoma, Malignant) 12/2016
1	Renal Insufficiency (Renal Failure) 06/2012
1	Thyroid Neoplasms (Thyroid Cancer) 06/2012
1	Stroke (Strokes) 05/2010
1	Arthritis (Polyarthritis) 05/2010
1	Neointima 11/2008
1	Carcinogenesis 05/2008
1	Pathologic Processes 11/2007
1	Heart Diseases (Heart Disease) 03/2006

Drug/Important Bio-Agent (IBA)

6	Endothelins (Endothelin)IBA 11/2020 - 03/2006
5	Matrix Metalloproteinases (MMPs)IBA 05/2010 - 05/2005
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2009
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 12/2016
3	AlbuminsIBA 01/2021 - 07/2014
3	Biological ProductsIBA 01/2021 - 05/2009
3	Endothelin A ReceptorIBA 11/2020 - 06/2012
3	Fluorescent Dyes (Fluorescent Probes)IBA 01/2020 - 01/2008
3	Peptides (Polypeptides)IBA 01/2018 - 11/2008
3	Coloring Agents (Dyes)IBA 05/2009 - 01/2008
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2020
2	Endothelin Receptors (Endothelin Receptor)IBA 01/2020 - 12/2017
2	gadofluorine PIBA 01/2020 - 04/2018
2	Pharmaceutical PreparationsIBA 01/2019 - 12/2016
2	arginyl-glycyl-aspartic acidIBA 01/2018 - 11/2008
2	IntegrinsIBA 01/2018 - 12/2014
2	Thromboplastin (Tissue Factor)IBA 12/2016 - 03/2013
1	Bevacizumab (Avastin)FDA Link 01/2021
1	Apolipoproteins E (ApoE)IBA 11/2020
1	gadofluorineIBA 01/2020
1	CathepsinsIBA 01/2020
1	Peptide Hydrolases (Proteases)FDA Link 01/2020
1	Gadolinium DTPA (Magnevist)FDA Link 04/2018
1	LigandsIBA 01/2018
1	VitronectinIBA 01/2018
1	Fibronectins (Fibronectin)IBA 01/2018
1	cyclic arginine-glycine-aspartic acid peptideIBA 01/2018
1	CilengitideIBA 01/2018
1	PhosphatidylserinesIBA 12/2016
1	Fibrinogen (Factor I)FDA Link 12/2014
1	N- (1- (2,3- dioleyloxy)propyl)- N,N,N- trimethylammoniumIBA 09/2014
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 03/2013
1	Membrane Proteins (Integral Membrane Proteins)IBA 03/2013
1	Fluorescein-5-isothiocyanate (FITC)IBA 05/2009
1	GelatinIBA 05/2009
1	GelatinasesIBA 05/2009
1	Integrin alphaVbeta3IBA 11/2008
1	ApolipoproteinsIBA 11/2008
1	Rubber (Elastica)IBA 11/2008
1	CD13 Antigens (Alanine Aminopeptidase)IBA 01/2008
1	NGR peptideIBA 01/2008
1	Metalloexopeptidases (Metalloexopeptidase)IBA 01/2008

Therapy/Procedure

4	Therapeutics 01/2021 - 03/2013
1	Secondary Prevention 01/2021
1	Precision Medicine 01/2021
1	Ligation 04/2018